Regional Health Properties, Inc. (RHEP)
OTCMKTS
· Delayed Price · Currency is USD
2.320
0.00 (0.00%)
May 9, 2025, 3:06 PM EDT
RHEP Revenue
In the year 2024, Regional Health Properties had annual revenue of $17.67M with 10.32% growth. Regional Health Properties had revenue of $5.56M in the quarter ending December 31, 2024, with 52.57% growth.
Revenue
17.67M
Revenue Growth
+10.32%
P/S Ratio
0.27
Revenue / Employee
69.01K
Employees
256
Market Cap
4.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.67M | 1.65M | 10.32% |
| Dec 31, 2023 | 16.01M | -15.00M | -48.36% |
| Dec 31, 2022 | 31.01M | 4.50M | 16.98% |
| Dec 31, 2021 | 26.51M | 9.85M | 59.17% |
| Dec 31, 2020 | 16.65M | -3.76M | -18.42% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |